Cargando…
Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643544/ https://www.ncbi.nlm.nih.gov/pubmed/25943189 http://dx.doi.org/10.1007/s10067-015-2932-z |
_version_ | 1782400533309423616 |
---|---|
author | Bykerk, Vivian P. Östör, Andrew J. K. Alvaro-Gracia, José Pavelka, Karel Ivorra, José Andrés Román Graninger, Winfried Bensen, William Nurmohamed, Michael T. Krause, Andreas Bernasconi, Corrado Aassi, Maher Sibilia, Jean |
author_facet | Bykerk, Vivian P. Östör, Andrew J. K. Alvaro-Gracia, José Pavelka, Karel Ivorra, José Andrés Román Graninger, Winfried Bensen, William Nurmohamed, Michael T. Krause, Andreas Bernasconi, Corrado Aassi, Maher Sibilia, Jean |
author_sort | Bykerk, Vivian P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4643544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-46435442015-11-19 Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice Bykerk, Vivian P. Östör, Andrew J. K. Alvaro-Gracia, José Pavelka, Karel Ivorra, José Andrés Román Graninger, Winfried Bensen, William Nurmohamed, Michael T. Krause, Andreas Bernasconi, Corrado Aassi, Maher Sibilia, Jean Clin Rheumatol Erratum Springer London 2015-05-06 2015 /pmc/articles/PMC4643544/ /pubmed/25943189 http://dx.doi.org/10.1007/s10067-015-2932-z Text en © International League of Associations for Rheumatology (ILAR) 2015 |
spellingShingle | Erratum Bykerk, Vivian P. Östör, Andrew J. K. Alvaro-Gracia, José Pavelka, Karel Ivorra, José Andrés Román Graninger, Winfried Bensen, William Nurmohamed, Michael T. Krause, Andreas Bernasconi, Corrado Aassi, Maher Sibilia, Jean Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice |
title | Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice |
title_full | Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice |
title_fullStr | Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice |
title_full_unstemmed | Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice |
title_short | Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice |
title_sort | erratum to: comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643544/ https://www.ncbi.nlm.nih.gov/pubmed/25943189 http://dx.doi.org/10.1007/s10067-015-2932-z |
work_keys_str_mv | AT bykerkvivianp erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT ostorandrewjk erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT alvarograciajose erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT pavelkakarel erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT ivorrajoseandresroman erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT graningerwinfried erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT bensenwilliam erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT nurmohamedmichaelt erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT krauseandreas erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT bernasconicorrado erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT aassimaher erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice AT sibiliajean erratumtocomparisonoftocilizumabasmonotherapyorwithaddondiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritisandinadequateresponsestoprevioustreatmentsanopenlabelstudyclosetoclinicalpractice |